These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36362069)

  • 1. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis.
    Wang W; Jia W; Zhang C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.
    Kumar N; Nakagawa P; Janic B; Romero CA; Worou ME; Monu SR; Peterson EL; Shaw J; Valeriote F; Ongeri EM; Niyitegeka JM; Rhaleb NE; Carretero OA
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1026-34. PubMed ID: 26962108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.
    Zuo Y; Chun B; Potthoff SA; Kazi N; Brolin TJ; Orhan D; Yang HC; Ma LJ; Kon V; Myöhänen T; Rhaleb NE; Carretero OA; Fogo AB
    Kidney Int; 2013 Dec; 84(6):1166-75. PubMed ID: 23739235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.
    Romero CA; Kumar N; Nakagawa P; Worou ME; Liao TD; Peterson EL; Carretero OA
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F195-F203. PubMed ID: 30403163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?
    Kassem KM; Vaid S; Peng H; Sarkar S; Rhaleb NE
    Can J Physiol Pharmacol; 2019 Jul; 97(7):589-599. PubMed ID: 30854877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
    Myöhänen TT; Tenorio-Laranga J; Jokinen B; Vázquez-Sánchez R; Moreno-Baylach MJ; García-Horsman JA; Männistö PT
    Br J Pharmacol; 2011 Aug; 163(8):1666-78. PubMed ID: 21133893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
    Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.
    Cavasin MA; Rhaleb NE; Yang XP; Carretero OA
    Hypertension; 2004 May; 43(5):1140-5. PubMed ID: 15037553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA
    Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ACE inhibition, and its therapeutic potential in hypertension and cardiovascular diseases.
    Kumar N; Yin C
    Pharmacol Res; 2018 Aug; 134():268-279. PubMed ID: 29990624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain.
    Hrenak J; Paulis L; Simko F
    Curr Pharm Des; 2015; 21(35):5135-43. PubMed ID: 26350537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Expression of Prolyl Oligopeptidase (POP) and Its Catalytic Products Ac-SDKP Contributes to the Ovarian Fibrosis Change in Polycystic Ovary Syndrome (PCOS) Mice.
    Han S; Wang S; Fan X; Chen M; Wang X; Huang Y; Zhang H; Ma Y; Wang J; Zhang C
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased endogenous levels of Ac-SDKP promote organ fibrosis.
    Cavasin MA; Liao TD; Yang XP; Yang JJ; Carretero OA
    Hypertension; 2007 Jul; 50(1):130-6. PubMed ID: 17470726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of N-acetyl-seryl-aspartyl-lysyl-proline with the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis attenuates pulmonary fibrosis in silicotic rats.
    Gao X; Xu H; Zhang B; Tao T; Liu Y; Xu D; Cai W; Wei Z; Li S; Zhang H; Mao N; Zhang G; Li D; Jin F; Li S; Zhang L; Liu H; Hao X; Yang F
    Exp Physiol; 2019 Oct; 104(10):1562-1574. PubMed ID: 31290182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review on biological effects and mechanism of Ac-SDKP].
    Liu AD; Yang F
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Feb; 41(2):149-155. PubMed ID: 36882283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
    Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW
    Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis.
    Zhang X; Zhou J; Zhu Y; He L; Pang Z; Wang Z; Xu C; Zhang C; Hao Q; Li W; Zhang W; Zhang Y; Li M
    IUBMB Life; 2019 Sep; 71(9):1302-1312. PubMed ID: 30900390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats.
    Peng H; Carretero OA; Raij L; Yang F; Kapke A; Rhaleb NE
    Hypertension; 2001 Feb; 37(2 Pt 2):794-800. PubMed ID: 11230375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
    Wang M; Liu R; Jia X; Mu S; Xie R
    Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.